$BDX
BECTON DICKINSON & CO Stock $bdx

$bdx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000001079523000098 Filed on November 21, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023
Revenue	$4.706B	$5.087B	$19.37B
YoY Change	2.62%	6.85%	2.66%
Cost Of Revenue	$2.679B	$3.386B	$11.20B
YoY Change	9.21%	26.11%	10.64%
Gross Profit	$2.027B	$1.701B	$8.170B
YoY Change	-4.97%	-18.06%	-6.58%
Gross Profit Margin	43.07%	33.44%	42.17%
Selling, General & Admin	$1.213B	$1.138B	$4.719B
YoY Change	2.19%	-3.72%	0.21%
% of Gross Profit	59.84%	66.9%	57.76%
Research & Development	$290.0M	$281.0M	$1.237B
YoY Change	-7.35%	-6.33%	-1.51%
% of Gross Profit	14.31%	16.52%	15.14%
Depreciation & Amortization	$561.0M	$587.0M	$2.288B
YoY Change	-1.06%	1.03%	2.65%
% of Gross Profit	27.68%	34.51%	28.0%
Operating Expenses	$1.503B	$1.478B	$5.956B
YoY Change	0.2%	-2.25%	-0.78%
Operating Profit	$439.0M	$223.0M	$2.111B
YoY Change	-24.96%	-60.46%	-23.01%
Interest Expense	$111.0M	-$104.0M	$452.0M
YoY Change	8.82%	7.22%	-218.32%
% of Operating Profit	25.28%	-46.64%	21.41%
Other Income/Expense, Net	-$4.000M	-$64.00M	-$46.00M
YoY Change	-50.0%	-11.11%	-60.68%
Pretax Income	$359.0M	$181.0M	$1.662B
YoY Change	-25.36%	-43.61%	-6.79%
Income Tax	$77.00M	$28.00M	$132.0M
% Of Pretax Income	21.45%	15.47%	7.94%
Net Earnings	$281.0M	$108.0M	$1.484B
YoY Change	-44.79%	-62.5%	-16.58%
Net Earnings / Revenue	5.97%	2.12%	7.66%
Basic Earnings Per Share	$0.97		$4.97
Diluted Earnings Per Share	$0.96	$0.36	$4.94
COMMON SHARES
Basic Shares Outstanding	290.4M shares		286.3M shares
Diluted Shares Outstanding	291.4M shares		288.4M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.182B	$1.424B	$1.424B
YoY Change	93.14%	40.43%	40.43%
Cash & Equivalents	$1.180B	$1.416B	$1.416B
Short-Term Investments	$2.000M	$8.000M	$8.000M
Other Short-Term Assets	$1.349B	$1.380B	$1.445B
YoY Change	-12.69%	-19.39%	-15.6%
Inventory	$3.304B	$3.273B	$3.273B
Prepaid Expenses
Receivables	$2.267B	$2.534B	$2.534B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.156B	$8.676B	$8.676B
YoY Change	-0.23%	6.57%	6.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.647B	$6.557B	$6.557B
YoY Change	6.4%	9.07%	9.07%
Goodwill	$24.60B	$24.52B
YoY Change	-0.67%	-0.4%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.259B	$2.078B	$2.077B
YoY Change	15.55%	12.39%	12.33%
Total Long-Term Assets	$44.12B	$44.10B	$44.10B
YoY Change	-1.86%	-1.54%	-1.54%
TOTAL ASSETS
Total Short-Term Assets	$8.156B	$8.676B	$8.676B
Total Long-Term Assets	$44.12B	$44.10B	$44.10B
Total Assets	$52.27B	$52.78B	$52.78B
YoY Change	-1.61%	-0.29%	-0.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.524B	$1.641B	$1.641B
YoY Change	1.6%	-3.41%	-3.41%
Accrued Expenses		$2.604B	$3.719B
YoY Change		-0.04%	-1.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$2.016B	$1.141B	$1.141B
YoY Change	-7.86%	-47.64%	-47.64%
Total Short-Term Liabilities	$7.540B	$6.641B	$6.641B
YoY Change	-1.11%	-14.98%	-14.98%
LONG-TERM LIABILITIES
Long-Term Debt	$14.09B	$14.74B	$14.74B
YoY Change	-1.22%	6.14%	6.14%
Other Long-Term Liabilities	$4.414B	$4.582B	$3.155B
YoY Change	-9.21%	422.46%	259.75%
Total Long-Term Liabilities	$18.51B	$19.32B	$17.89B
YoY Change	-3.25%	30.87%	21.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.540B	$6.641B	$6.641B
Total Long-Term Liabilities	$18.51B	$19.32B	$17.89B
Total Liabilities	$26.05B	$25.96B	$26.98B
YoY Change	-2.64%	-6.05%	-2.35%
SHAREHOLDERS EQUITY
Retained Earnings	$15.54B	$15.54B
YoY Change	1.01%	2.49%
Common Stock	$20.11B	$20.09B
YoY Change	0.79%	0.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$8.828B	$8.305B
YoY Change	5.94%	-0.3%
Treasury Stock Shares
Shareholders Equity	$25.33B	$25.80B	$25.80B
YoY Change
Total Liabilities & Shareholders Equity	$52.27B	$52.78B	$52.78B
YoY Change	-1.61%	-0.29%	-0.29%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	$281.0M	$108.0M	$1.484B
YoY Change	-44.79%	-62.5%	-16.58%
Depreciation, Depletion And Amortization	$561.0M	$587.0M	$2.288B
YoY Change	-1.06%	1.03%	2.65%
Cash From Operating Activities	$841.0M	$1.324B	$2.989B
YoY Change	110.78%	36.21%	13.48%
INVESTING ACTIVITIES
Capital Expenditures	$116.0M	$294.0M	$874.0M
YoY Change	-44.23%	-193.33%	-189.83%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$116.0M	$431.0M	$382.0M
YoY Change	39.76%	-125.5%	-116.92%
Cash From Investing Activities	-$233.0M	$137.0M	-$716.0M
YoY Change	-19.93%	-106.83%	-77.84%
FINANCING ACTIVITIES
Cash Dividend Paid	$275.0M
YoY Change	-2.14%
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$0.00		$2.155B
YoY Change	-100.0%		167.7%
Cash From Financing Activities	-$862.0M	-997.0M	-1.956B
YoY Change	61.42%	81.6%	230.96%
NET CHANGE
Cash From Operating Activities	841.0M	1.324B	2.989B
Cash From Investing Activities	-$233.0M	137.0M	-716.0M
Cash From Financing Activities	-$862.0M	-997.0M	-1.956B
Net Change In Cash	-$247.0M	464.0M	$322.0M
YoY Change	-40.48%	-129.33%	-127.1%
FREE CASH FLOW
Cash From Operating Activities	$841.0M	$1.324B	$2.989B
Capital Expenditures	$116.0M	$294.0M	$874.0M
Free Cash Flow	$725.0M	$1.030B	$2.115B
YoY Change	279.58%	-19.97%	-41.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	508000000	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2333000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2801000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	26000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	287364000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	292089000	shares
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2002000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.14
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.42
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	70252717647	usd
CY2023	dei	Auditor Name AuditorName	ERNST & YOUNG LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	210000000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	17261000000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	16588000000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2111000000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2282000000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	2250000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	452000000	usd
CY2022	us-gaap	Interest Expense InterestExpense	398000000	usd
CY2021	us-gaap	Interest Expense InterestExpense	469000000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	49000000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	16000000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46000000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-117000000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-99000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1662000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1783000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1692000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	132000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1530000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1635000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1604000000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-46000000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	144000000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	488000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1484000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1779000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2092000000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	60000000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	90000000	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	90000000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1424000000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1689000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	5.23
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.16
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.50
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.69
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.10
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.38
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	5.18
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.16
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.50
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	1.67
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.85
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-91000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-4000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-210000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	27000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	85000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	81000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-60000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	600000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	460000000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1424000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2379000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2552000000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1416000000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1006000000	usd
CY2023Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	65000000	usd
CY2022Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	153000000	usd
CY2023Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	8000000	usd
CY2022Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	8000000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2534000000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2191000000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	3273000000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	3224000000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1380000000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1559000000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8676000000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	8141000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6557000000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6012000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	24522000000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	24621000000	usd
CY2023Q3	bdx	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	8058000000	usd
CY2022Q3	bdx	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	9108000000	usd
CY2023Q3	bdx	Finite Lived Customer Relationships Net FiniteLivedCustomerRelationshipsNet	2338000000	usd
CY2022Q3	bdx	Finite Lived Customer Relationships Net FiniteLivedCustomerRelationshipsNet	2683000000	usd
CY2023Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	552000000	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	519000000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2078000000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1848000000	usd
CY2023Q3	us-gaap	Assets Assets	52780000000	usd
CY2022Q3	us-gaap	Assets Assets	52934000000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	1141000000	usd
CY2022Q3	us-gaap	Debt Current DebtCurrent	2179000000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1641000000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1699000000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2604000000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2605000000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1115000000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1171000000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	139000000	usd
CY2022Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	157000000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6641000000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7811000000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14738000000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13886000000	usd
CY2023Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	1023000000	usd
CY2022Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	902000000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4582000000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5052000000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	2000000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	640000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	640000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	370594401	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364639901	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	371000000	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	365000000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	19720000000	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	19553000000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15535000000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	15157000000	usd
CY2023Q3	bdx	Common Stock Shares Held In Employee Trust1 CommonStockSharesHeldInEmployeeTrust1	24000000	usd
CY2022Q3	bdx	Common Stock Shares Held In Employee Trust1 CommonStockSharesHeldInEmployeeTrust1	23000000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	80202608	shares
CY2022Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81283191	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	8305000000	usd
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	8330000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1548000000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1488000000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	25796000000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	25282000000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52780000000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52934000000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1484000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1779000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2092000000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-46000000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	144000000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	488000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1530000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1635000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1604000000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2288000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2229000000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2230000000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	259000000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	233000000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-622000000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	290000000	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-32000000	usd
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	61000000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15000000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	631000000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	83000000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-192000000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	436000000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	184000000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-517000000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-473000000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	660000000	usd
CY2023	bdx	Increase Decreasein Pension Benefit Obligation IncreaseDecreaseinPensionBenefitObligation	112000000	usd
CY2022	bdx	Increase Decreasein Pension Benefit Obligation IncreaseDecreaseinPensionBenefitObligation	-55000000	usd
CY2021	bdx	Increase Decreasein Pension Benefit Obligation IncreaseDecreaseinPensionBenefitObligation	71000000	usd
CY2023	bdx	Excess Tax Benefit From Payments Under Share Based Compensation Operating Activities ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities	-19000000	usd
CY2022	bdx	Excess Tax Benefit From Payments Under Share Based Compensation Operating Activities ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities	-32000000	usd
CY2021	bdx	Excess Tax Benefit From Payments Under Share Based Compensation Operating Activities ExcessTaxBenefitFromPaymentsUnderShareBasedCompensationOperatingActivities	-15000000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	268000000	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2023	us-gaap	Inventory Recall Expense InventoryRecallExpense	653000000	usd
CY2022	us-gaap	Inventory Recall Expense InventoryRecallExpense	72000000	usd
CY2021	us-gaap	Inventory Recall Expense InventoryRecallExpense	56000000	usd
CY2023	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	26000000	usd
CY2022	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	21000000	usd
CY2021	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	361000000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	377000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2990000000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	874000000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2070000000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	540000000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	382000000	usd
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	178000000	usd
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	142000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-716000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3220000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1843000000	usd
CY2023	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	-230000000	usd
CY2022	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	230000000	usd
CY2021	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1662000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	497000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4869000000	usd
CY2023	bdx	Proceeds From Spinoff Transaction ProceedsFromSpinoffTransaction	0	usd
CY2022	bdx	Proceeds From Spinoff Transaction ProceedsFromSpinoffTransaction	1266000000	usd
CY2021	bdx	Proceeds From Spinoff Transaction ProceedsFromSpinoffTransaction	0	usd
CY2023	bdx	Cash Transfer Related To Spinoff Transaction CashTransferRelatedToSpinoffTransaction	0	usd
CY2022	bdx	Cash Transfer Related To Spinoff Transaction CashTransferRelatedToSpinoffTransaction	265000000	usd
CY2021	bdx	Cash Transfer Related To Spinoff Transaction CashTransferRelatedToSpinoffTransaction	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2155000000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	805000000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5112000000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1750000000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1114000000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1082000000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1048000000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-120000000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-77000000	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-265000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1956000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-736000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-3306000000	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1000000	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	163000000	usd
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	521000000	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-11000000	usd
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-37000000	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	145000000	usd
CY2021	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-1000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	298000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	484000000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5000000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-45000000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15000000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	322000000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1233000000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-525000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1159000000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2392000000	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2917000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1481000000	usd
CY2023	us-gaap	Depreciation Depreciation	696000000	usd
CY2022	us-gaap	Depreciation Depreciation	672000000	usd
CY2021	us-gaap	Depreciation Depreciation	689000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1662000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1783000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1692000000	usd
CY2023	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	874000000	usd
CY2022	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	973000000	usd
CY2021	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	1194000000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2288000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2229000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates or assumptions affect reported assets, liabilities, revenues and expenses as reflected in the consolidated financial statements. Actual results could differ from these estimates.</span></div>
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2230000000	usd
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsForfeitedInPeriod	230000	shares
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsForfeitedInPeriodWeightedAverageExercisePrice	253.21
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber	4905000	shares
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice	211.47
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.32
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.48
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.64
CY2013Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	10000000	shares
CY2021Q4	bdx	Stock Repurchase Program Number Of Additional Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased	10000000	shares
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2548000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	383000000	usd
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-77000000	usd
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2088000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	306000000	usd
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-43000000	usd
CY2022	us-gaap	Stockholders Equity Note Spinoff Transaction StockholdersEquityNoteSpinoffTransaction	251000000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1488000000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-106000000	usd
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-46000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1548000000	usd
CY2023	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	-15000000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	47000000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	42000000	usd
CY2022Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingNumber	5544000	shares
CY2022Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageExercisePrice	197.31
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriod	752000	shares
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsGrantsInPeriodWeightedAverageExercisePrice	238.06
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriod	1161000	shares
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisesInPeriodWeightedAverageExercisePrice	156.11
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	286282000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	285005000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	289288000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2110000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	288392000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2023	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	1621000000	usd
CY2023Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1900000000	usd
CY2022Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	2100000000	usd
CY2023Q3	bdx	Contract With Customer Rebate Liability ContractWithCustomerRebateLiability	538000000	usd
CY2022Q3	bdx	Contract With Customer Rebate Liability ContractWithCustomerRebateLiability	525000000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	412000000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3Y
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	bdx	Number Of Customer Accounted For Ten Percent Or More Of Revenue NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue	0	customer
CY2022	bdx	Number Of Customer Accounted For Ten Percent Or More Of Revenue NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue	0	customer
CY2023	bdx	Number Of Customer Accounted For Ten Percent Or More Of Revenue NumberOfCustomerAccountedForTenPercentOrMoreOfRevenue	0	customer
CY2023	us-gaap	Revenues Revenues	19372000000	usd
CY2022	us-gaap	Revenues Revenues	18870000000	usd
CY2021	us-gaap	Revenues Revenues	19131000000	usd
CY2023	us-gaap	Revenues Revenues	19372000000	usd
CY2022	us-gaap	Revenues Revenues	18870000000	usd
CY2021	us-gaap	Revenues Revenues	19131000000	usd
CY2023Q3	us-gaap	Noncurrent Assets NoncurrentAssets	44104000000	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	44792000000	usd
CY2021Q3	us-gaap	Noncurrent Assets NoncurrentAssets	44606000000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	261000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	240000000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	238000000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	58000000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	55000000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	55000000	usd
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Award Vesting Period ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsAwardVestingPeriod	P4Y
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsTermsOfAward	P10Y
CY2023	bdx	Stock Issued Under Stock Appreciation Rights Exercised StockIssuedUnderStockAppreciationRightsExercised	500000	shares
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P5Y7M28D
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsOutstandingIntrinsicValue	231000000	usd
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingNumber	4757000	shares
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	210.67
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm	P5Y6M29D
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	228000000	usd
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableNumber	3428000	shares
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisableWeightedAverageExercisePrice	200.41
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm	P4Y6M10D
CY2023Q3	bdx	Share Based Compensation Arrangement By Share Based Payments Award Stock Appreciation Rights Exercisable Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentsAwardStockAppreciationRightsExercisableIntrinsicValue	199000000	usd
CY2023	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue	126000000	usd
CY2022	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue	184000000	usd
CY2021	bdx	Share Based Compensation Arrangement By Share Based Payment Award Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardStockAppreciationRightsExercisesInPeriodIntrinsicValue	102000000	usd
CY2023	bdx	Fair Value Of Stock Appreciation Rights FairValueOfStockAppreciationRights	34000000	usd
CY2022	bdx	Fair Value Of Stock Appreciation Rights FairValueOfStockAppreciationRights	36000000	usd
CY2021	bdx	Fair Value Of Stock Appreciation Rights FairValueOfStockAppreciationRights	39000000	usd
CY2023	bdx	Percentage Of Target Payout On Which Performance Based Restricted Stock Units Are Based PercentageOfTargetPayoutOnWhichPerformanceBasedRestrictedStockUnitsAreBased	2
CY2023	bdx	Percentage Of Target Payout On Which Performance Based Time Vested Restricted Stock Units Are Based PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased	1
CY2023	bdx	Percentage Of Target Payout On Which Performance Based Time Vested Restricted Stock Units Are Based PercentageOfTargetPayoutOnWhichPerformanceBasedTimeVestedRestrictedStockUnitsAreBased	1
CY2023	bdx	Expected Forfeited Performance Based Restricted Stock Units ExpectedForfeitedPerformanceBasedRestrictedStockUnits	69000	shares
CY2023	bdx	Units In Excess Of Expected Performance Payout UnitsInExcessOfExpectedPerformancePayout	297000	shares
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	272000000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5600000	shares
CY2023Q3	bdx	Shares Issuable Under Deferred Compensation Plan SharesIssuableUnderDeferredCompensationPlan	211000	shares
CY2023Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation	2140000000	usd
CY2022Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation	2104000000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	2159000000	usd
CY2022Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation	2182000000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	2088000000	usd
CY2022Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation	2059000000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	1575000000	usd
CY2022Q3	us-gaap	Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets	1644000000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	1591000000	usd
CY2022Q3	us-gaap	Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Plan Assets DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets	1720000000	usd
CY2023	bdx	Percent Of Assets Domestic Plans PercentOfAssetsDomesticPlans	0.65
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	156000000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	178000000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	153000000	usd
CY2020Q3	us-gaap	Restructuring Reserve RestructuringReserve	36000000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	44000000	usd
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	56000000	usd
CY2021	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	4000000	usd
CY2021Q3	us-gaap	Restructuring Reserve RestructuringReserve	19000000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	123000000	usd
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	82000000	usd
CY2022	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	25000000	usd
CY2022	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	1000000	usd
CY2022Q3	us-gaap	Restructuring Reserve RestructuringReserve	35000000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	239000000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	165000000	usd
CY2023	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	30000000	usd
CY2023	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-1000000	usd
CY2023Q3	us-gaap	Restructuring Reserve RestructuringReserve	80000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	21069000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10168000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10901000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	20987000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8723000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12264000000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	46000000	usd
CY2022Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	46000000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1465000000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1430000000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1402000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1434000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1431000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1398000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1327000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1239000000	usd
CY2021Q3	us-gaap	Goodwill Goodwill	23886000000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1073000000	usd
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-1000000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	337000000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	24621000000	usd
CY2023	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	218000000	usd
CY2023	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	13000000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-105000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	24522000000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1416000000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1006000000	usd
CY2023Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	65000000	usd
CY2022Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	153000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1481000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1159000000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	373000000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1000000	usd
CY2023Q3	bdx	Fair Value Of Debt Classified From Long Term To Short Term FairValueOfDebtClassifiedFromLongTermToShortTerm	1122000000	usd
CY2022Q3	bdx	Fair Value Of Debt Classified From Long Term To Short Term FairValueOfDebtClassifiedFromLongTermToShortTerm	1927000000	usd
CY2023Q3	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	12850000000	usd
CY2022Q3	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	12119000000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash deposits in excess of government-provided insurance limits. Such cash deposits are exposed to loss in the event of nonperformance by financial institutions. Substantially all of the Company’s trade receivables are due from public and private entities involved in the healthcare industry. Due to the large size and diversity of the Company’s customer base, concentrations of credit risk with respect to trade receivables are limited. The Company does not normally require collateral. The Company is exposed to credit loss in the event of nonperformance by financial institutions with which it conducts business. However, this loss is limited to the amounts, if any, by which the obligations of the counterparty to the financial instrument contract exceed the obligations of the Company. The Company also minimizes exposure to credit risk by dealing with a diversified group of major financial institutions.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its accounts receivables for potential collection risks, particularly those resulting from sales to government-owned or government-supported healthcare facilities in certain countries, as payment may be dependent upon the financial stability and creditworthiness of those countries’ </span></div>national economies. The Company continually evaluates all governmental receivables for potential collection risks associated with the availability of government funding and reimbursement practices. The Company believes the current reserves related to all governmental receivables are adequate and that this concentration of credit risk will not have a material adverse impact on its financial position or liquidity.
CY2023	bdx	Transfers Of Financial Assets During The Period TransfersOfFinancialAssetsDuringThePeriod	2615000000	usd
CY2022	bdx	Transfers Of Financial Assets During The Period TransfersOfFinancialAssetsDuringThePeriod	1215000000	usd
CY2021	bdx	Transfers Of Financial Assets During The Period TransfersOfFinancialAssetsDuringThePeriod	1189000000	usd
CY2023Q3	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	357000000	usd
CY2022Q3	us-gaap	Transfer Of Financial Assets Accounted For As Sales Amount Derecognized TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized	323000000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	1141000000	usd
CY2022Q3	us-gaap	Debt Current DebtCurrent	2179000000	usd
CY2023Q3	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0343
CY2022Q3	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0100
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14738000000	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13886000000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1625000000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2161000000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1073000000.000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2916000000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2183000000	usd
CY2023Q1	bdx	Letters Of Credit Issuable Under Credit Facility LettersOfCreditIssuableUnderCreditFacility	100000000	usd
CY2023Q1	bdx	Swingline Loans Issuable Under Credit Facility SwinglineLoansIssuableUnderCreditFacility	194000000	usd
CY2023Q1	bdx	Line Of Credit Facility Maximum Additional Principal Amount Commitments LineOfCreditFacilityMaximumAdditionalPrincipalAmountCommitments	500000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	3250000000	usd
CY2022	bdx	Gain Loss From Reverse Treasury Locks GainLossFromReverseTreasuryLocks	-17000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	452000000	usd
CY2022	us-gaap	Interest Expense InterestExpense	398000000	usd
CY2021	us-gaap	Interest Expense InterestExpense	469000000	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	51000000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	46000000	usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	44000000	usd
CY2023	us-gaap	Interest Costs Incurred InterestCostsIncurred	503000000	usd
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	444000000	usd
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	512000000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	452000000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	390000000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	474000000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	364000000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	17000000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	72000000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	87000000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	32000000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	42000000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	303000000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	228000000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	254000000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	754000000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	277000000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	368000000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-644000000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-96000000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-284000000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	22000000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-33000000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	4000000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-622000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-129000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-280000000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	132000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	88000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	358000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	496000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	70000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1304000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1287000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	1623000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1662000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1783000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1692000000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	267000000	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	354000000	usd
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	611000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	22000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	40000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	23000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	33000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	60000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	5000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	29000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	4000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	6000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	77000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	183000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	18000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	112000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	100000000	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	354000000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	366000000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	348000000	usd
CY2021Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	447000000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	20000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-6000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	5000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	426000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	430000000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	409000000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	412000000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	1858000000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	2064000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	2352000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	2185000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	362000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	133000000	usd
CY2023Q3	bdx	Deferred Tax Assets Tax Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetsTaxDeferredExpenseCapitalizedResearchAndDevelopmentCosts	243000000	usd
CY2022Q3	bdx	Deferred Tax Assets Tax Deferred Expense Capitalized Research And Development Costs DeferredTaxAssetsTaxDeferredExpenseCapitalizedResearchAndDevelopmentCosts	63000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	531000000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	183000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	524000000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	260000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3914000000	usd
CY2023Q3	bdx	Deferred Tax Liabilities Gross DeferredTaxLiabilitiesGross	2450000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3335000000	usd
CY2022Q3	bdx	Deferred Tax Liabilities Gross DeferredTaxLiabilitiesGross	2736000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2272000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2093000000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1642000000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2450000000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1242000000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2736000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.010
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.027
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.082
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.073
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.064
CY2023	bdx	Effective Income Tax Rate Reconciliation Effect Of Foreign Operations Percent EffectiveIncomeTaxRateReconciliationEffectOfForeignOperationsPercent	-0.039
CY2022	bdx	Effective Income Tax Rate Reconciliation Effect Of Foreign Operations Percent EffectiveIncomeTaxRateReconciliationEffectOfForeignOperationsPercent	0.056
CY2021	bdx	Effective Income Tax Rate Reconciliation Effect Of Foreign Operations Percent EffectiveIncomeTaxRateReconciliationEffectOfForeignOperationsPercent	-0.010
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.032
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.022
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.020
CY2023	bdx	Effective Income Tax Rate Reconciliation Benefit From Share Based Compensation EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation	-0.004
CY2022	bdx	Effective Income Tax Rate Reconciliation Benefit From Share Based Compensation EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation	-0.017
CY2021	bdx	Effective Income Tax Rate Reconciliation Benefit From Share Based Compensation EffectiveIncomeTaxRateReconciliationBenefitFromShareBasedCompensation	0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0.032
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Assets EffectiveIncomeTaxRateReconciliationDispositionOfAssets	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.055
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.022
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.016
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.079
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.083
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.052
CY2023	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	363000000	usd
CY2022	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	284000000	usd
CY2021	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	243000000	usd
CY2023	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	1.26
CY2022	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.99
CY2021	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.83
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	629000000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	532000000	usd
CY2023	bdx	Deferred Compensation Investment Income Expense DeferredCompensationInvestmentIncomeExpense	32000000	usd
CY2022	bdx	Deferred Compensation Investment Income Expense DeferredCompensationInvestmentIncomeExpense	-46000000	usd
CY2021	bdx	Deferred Compensation Investment Income Expense DeferredCompensationInvestmentIncomeExpense	43000000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	671000000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.032
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	145000000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	138000000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	132000000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	517000000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	482000000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	117000000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	118000000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	414000000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	384000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	132000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	114000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	89000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	62000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	45000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	153000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	595000000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	64000000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	531000000	usd
CY2021	bdx	Gross Proceeds From Sale Leaseback Transaction GrossProceedsFromSaleLeasebackTransaction	225000000	usd
CY2023	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-3000000	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-35000000	usd
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	57000000	usd
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	98000000	usd
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	17000000	usd
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1000000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-36000000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-28000000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-13000000	usd
CY2023	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	0	usd
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-24000000	usd
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	-178000000	usd
CY2023	bdx	Embecta Services Agreement Income Loss Net EmbectaServicesAgreementIncomeLossNet	59000000	usd
CY2022	bdx	Embecta Services Agreement Income Loss Net EmbectaServicesAgreementIncomeLossNet	33000000	usd
CY2021	bdx	Embecta Services Agreement Income Loss Net EmbectaServicesAgreementIncomeLossNet	0	usd
CY2023	bdx	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	0	usd
CY2022	bdx	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	1000000	usd
CY2021	bdx	Other Other Nonoperating Income Expense OtherOtherNonoperatingIncomeExpense	-6000000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46000000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-117000000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-99000000	usd
CY2020Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	88000000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	101000000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	97000000	usd
CY2021Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	91000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	77000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	87000000	usd
CY2022Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81000000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	109000000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	110000000	usd
CY2023Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	81000000	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	714000000	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	707000000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	381000000	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	397000000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2178000000	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2120000000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	3273000000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	3224000000	usd
CY2023Q3	us-gaap	Land Land	131000000	usd
CY2022Q3	us-gaap	Land Land	127000000	usd
CY2023Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3537000000	usd
CY2022Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3252000000	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9609000000	usd
CY2022Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	8769000000	usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	301000000	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	266000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13578000000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12415000000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7021000000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6402000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6557000000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6012000000	usd
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	42

Files In Submission

Name	View Source	Status
bdx-20230930_cal.xml	Edgar Link	unprocessable
bdx-20230930_def.xml	Edgar Link	unprocessable
0000010795-23-000098-index-headers.html	Edgar Link	pending
0000010795-23-000098-index.html	Edgar Link	pending
0000010795-23-000098.txt	Edgar Link	pending
0000010795-23-000098-xbrl.zip	Edgar Link	pending
a09-30x2023ex10c.htm	Edgar Link	pending
a09-30x2023ex10gi.htm	Edgar Link	pending
a09-30x2023ex21.htm	Edgar Link	pending
a09-30x2023ex22.htm	Edgar Link	pending
a09-30x2023ex23.htm	Edgar Link	pending
a09-30x2023ex31.htm	Edgar Link	pending
a09-30x2023ex32.htm	Edgar Link	pending
a09-30x2023ex4ee.htm	Edgar Link	pending
bdx-20230930.htm	Edgar Link	pending
bdx-20230930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
bdx-20230930_lab.xml	Edgar Link	unprocessable
bdx-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bdx-20230930_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDX
BECTON DICKINSON & CO Stock $bdx

2023 Q4 Form 10-K Financial Statement

#000001079523000098 Filed on November 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDX BECTON DICKINSON & CO Stock $bdx

2023 Q4 Form 10-K Financial Statement

#000001079523000098 Filed on November 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDX
BECTON DICKINSON & CO Stock $bdx